Kangmei Pharmaceutical Co., Ltd. (SHA: 600518)
China
· Delayed Price · Currency is CNY
2.240
-0.060 (-2.61%)
Jan 3, 2025, 3:00 PM CST
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 31.06 billion as of January 3, 2025. Its market cap has increased by 18.52% in one year.
Market Cap
31.06B
Enterprise Value
30.53B
Revenue
5.21B
Ranking
n/a
PE Ratio
121.53
Stock Price
2.24
Market Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 31.06B, an increase of 1,104.37%. That is a compound annual growth rate of 11.02%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 299.75B |
Jiangsu Hengrui Medicine | 285.82B |
WuXi AppTec | 152.01B |
Zhangzhou Pientzehuang Pharmaceutical., | 126.13B |
Aier Eye Hospital Group | 118.26B |
Yunnan Baiyao Group Co.,Ltd | 103.58B |
Shanghai United Imaging Healthcare | 103.27B |
Beijing Wantai Biological Pharmacy Enterprise | 85.14B |